Vnitr Lek 2006, 52(1):17-20

Antikoagulační léčba u antifosfolipidového syndromu - editorial

Z. Fojtík
Revmatologická ambulance Interní hematoonkologické kliniky Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jiří Vorlíček, CSc.

Received: November 28, 2005; Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fojtík Z. Antikoagulační léčba u antifosfolipidového syndromu - editorial. Vnitr Lek. 2006;52(1):17-20.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bevers EM, Galli M, Barbui T et al. Lupus anticoagulant IgGs (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-632. Go to original source... Go to PubMed...
    2. Bowie EJW, Thompson JH, Pascuzzi CA et al. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416-430.
    3. Conley CL, Hartmann RC. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952; 31: 621-622.
    4. Crowther MA, Ginsberg JS, Julian J et al. Comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003; 349: 1133-1138. Go to original source... Go to PubMed...
    5. Derksen RH, de Groot PG, Kater L et al. Patients with antiphospholipid antibodies and venous thrombosis should receive long-term anticoagulant treatment. Ann Rheum Dis 1993; 52: 689-692. Go to original source... Go to PubMed...
    6. Erkan D, Ortel TL, Lockshin MD. Warfarin in antiphospholipid syndrome - time to explore new horizons. J Rheumatol 2005; 32: 208-212. Go to PubMed...
    7. Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hemostas Thromb 1972; 1: 75-95.
    8. Fojtík Z, Beránek M, Klabusay M et al. Výskyt vybraných antifosfolipidových protilátek u skupiny nemocných se systémovým lupus erythematodes. Vnitř Lék 2004; 50: 267-273. Go to PubMed...
    9. Galli M, Comfurius P, Maasen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-1547. Go to original source... Go to PubMed...
    10. Ginsberg J, Wells P, Brill-Edwards P et al. Antiphospholipid antibodies and venous thrombembolism. Blood 1995; 86: 3685-3691. Go to original source...
    11. Godfrey T, Cruz D. Antiphospholipid syndrome: general features. In: Hughes syndrome. Antiphospholipid syndrome. London: Springer-Verlag 2000: 8-19. Go to original source...
    12. Harris EN, Gharavi AE, Boey ML et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 338: 1211-1214. Go to original source... Go to PubMed...
    13. Harris EN, Baguley E, Asherson RA et al. Clinical and serological features of the antiphospholipid syndrome. Abstract. Br J Rhematol 1987; 26: 19.
    14. Hughes GRV. Thrombosis, abortion, cerebral disease and lupus anticoagulant. Br Med J 1983; 187: 1088-1089. Go to original source... Go to PubMed...
    15. Hughes GRV. The anticardiolipin syndrome. Clin Exp Rheumatol 1985; 3: 285. Go to PubMed...
    16. Kearon C, Gent M, Hirsh J et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-907. Go to original source... Go to PubMed...
    17. Levine SR, Brey RL, Tilley BC et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004; 291: 576-584. Go to original source... Go to PubMed...
    18. Loeliger A. Prothrombin as a co-factor of the circulating anticoagulant in systemic lupus erythematosus? Thromb Diath Haemorrh 1959; 3: 237-256. Go to original source...
    19. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Internal Med 1990; 112: 682-698. Go to original source... Go to PubMed...
    20. McNeil HP, Simpson RJ, Chesterman CJ et al. Antiphospholipid antibodies are directed against a complex antigen that ancludes lipid binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124. Go to original source... Go to PubMed...
    21. Moore JE, Mohr CHF. Biologically false positive serologic test for syphilis. JAMA 1952; 50: 467-473. Go to original source... Go to PubMed...
    22. Pierangeli SS, Gharavi AE, Harris EN. Anticardiolipin testing. In: Hughes syndrome. Antiphospholipid syndrome. London: Springer-Verlag 2000: 205-213. Go to original source...
    23. Pangborn MC. A new serologically active phospholipid from beef heart. Proc Soc Exp Biol Med 1941; 48: 484-486. Go to original source...
    24. Ruiz-Irastorza G, Khamashta MA, Hunt BJ et al. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3,5. Arch Intern Med 2002; 162: 1164-1169. Go to original source... Go to PubMed...
    25. Schulman S, Svenungsson E, Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Am J Med 1998; 104: 332-338. Go to original source... Go to PubMed...
    26. Triplett DA. Many faces of lupus anticoagulants. Lupus 1998; 7(Suppl 2): 18-22. Go to original source... Go to PubMed...
    27. Wahl DG, Guillemin F, deMaistre E et al. Metaanalysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus 1998; 7: 15-22. Go to original source... Go to PubMed...
    28. Wasserman A, Neisser A, Bruck C. Eine serodiagnostische Reaktion bei Syphylis. Deutsch Med Wochenschr 1906; 32: 475-489. Go to original source...
    29. Wilson WA. Classification criteria for antiphospholipid syndrome. Rheum Dis Clin 2001; 37: 499-505. Go to original source... Go to PubMed...
    30. Weber M, Hayem G, de Bandt M et al. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrom? J Rheumatol 1999; 26: 2131-2136. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.